NCT00310557View on ClinicalTrials.gov

Magnevist® Injection-enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis of the Renal Arteries

PHASE3CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

December 31, 2004

Conditions
Renal Artery Stenosis
Interventions
DRUG

Gadopentetate dimeglumine (Magnevist)

Approximately 0.1mmol/kg body weight, single intravenous administration on the study day

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY